Herein, we review recent progress in understanding of the tissue distributions, biological characteristics and antitumor mechanisms of CD8+Trm cells in EC, GC, HCC and CRC to provide directions for combined precision targeted therapy strategies and prognosis prediction. This evidence concerns the gene CD8A and hepatocellular carcinoma.